Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Cancer. 2017 Dec 13;124(5):899–906. doi: 10.1002/cncr.31144

Figure 3.

Figure 3

Figure 3

AML (A) and MDS (B) Cumulative Incidence (%) by adjuvant chemotherapy use among older patients with localized and regional breast cancer, subjects to competing risk of death. Numbers of patients at risk at each time point are listed.